Zurueck zur Suche

Reporte zur Charge U039951

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 5 ID 1 OR 1 NY 1 CA 1 WA 1 WI 1 OH 1

VAERS 2600310

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
ID
Alter
1,3
Geschlecht
F
Eingang
21.03.2023
Impfdatum
20.03.2023
Beginn
21.03.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye swelling Scratch Secretion discharge

Symptomtext

Approximately 4 hours post vaccination started scratching her neck, increased mucus production and swollen eyes. Parent gave benadryl and symptoms abated. Report to complete and encouraged parent to discuss with primary care provider next steps to vaccinating or if medical exemption is needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Some runny nose
Vorgeschichte
None identified
Andere Medikamente
None identified
Allergien
None identified
Vorherige Impfungen
-

VAERS 2570548

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
OR
Alter
11,0
Geschlecht
M
Eingang
30.01.2023
Impfdatum
25.01.2023
Beginn
25.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient due for HPV immunization. HIB vaccine accidently given instead of HPV. Vaccine checked by 2 people prior to administration of vaccine but mistake was not caught prior to administration. Parent told of incident at time. Nurse Practitioner denied possible adverse reactions from wrong vaccine. Patient and parent denied adverse reactions at time of administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Stoamch pain with diahrrea
Vorgeschichte
none
Andere Medikamente
Ventolin HFA inhaler; Singulair 5 mg daily; Zyrtec 5 mg daily;
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2510207

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
17.11.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs were reported; patient received improperly stored vaccines; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided. On 21-OCT-2022, the patient was vaccinated with following improperly stored vaccines: haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 1 dose, lot # U039951 with expiration date 22-JUN-2024, for prophylaxis (exact dose, route of administration and injection site were not provided); rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dose, lot # 1912561 was confirmed to be valid, with expiration date 10-DEC-2023, administered orally for prophylaxis (exact dose was not provided) (product storage error). The vaccines were improperly stored for 15 minutes in the temperature of 34.9 degrees Fahrenheit (F). It was unknown if data logger was used to capture the temperature excursion. There were no previous temperature excursions. No additional adverse events were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2499391

GLAXOSMITHKLINE BIOLOGICALS · HIB (HIBERIX) · Charge U039951

gering
Staat
CA
Alter
1,0
Geschlecht
M
Eingang
04.11.2022
Impfdatum
05.10.2022
Beginn
07.10.2022
Tage bis Beginn
2,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contusion Induration Mass

Symptomtext

bruise noted on day 2, then bruise resolved and small, firm, mobile, subcutansous mass was noted. Mass is slowly getting smaller, but still present 1 month later 11/04/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Contusion
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2474329

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
11.10.2022
Impfdatum
05.10.2022
Beginn
05.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; Nurse reporting an AE for PEDVAXHIB and ROTATEQ being administered after a temperature excursion that occurred on 05-OCT-2022.; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 05-OCT-2022, the patient was vaccinated with improperly stored (product storage error) doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 milliliter, lot #: 1879874, expiration date: 19-OCT-2023; and haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 milliliter, lot #: U039951, expiration date: 22-JUN-2024 (strengths, sites and routes of administration were not provided for both suspect vaccines) for prophylaxis. Temperature excursion information for haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB): 47.4 degree Fahrenheit for 30 minutes; previous temperature excursion: approximately August 2022, 49.8 degree Fahrenheit for 2 hours 25 minutes. Temperature excursion information for rotavirus vaccine, live, oral, pentavalent (ROTATEQ): 47.4 degree Fahrenheit for 30 minutes; no previous temperature excursion. There was no additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2463929

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
29.09.2022
Impfdatum
10.08.2022
Beginn
10.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event Product preparation error

Symptomtext

No additional AE information provided.; HCP states that multiple patients have accidentally been given PEDVAXHIB vaccine that was diluted; HCP states that the personadministering the product was diluting the PEDVAXHIB with 0.5mL of normal saline and then drawing up 0.5mL and administering it; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 10-AUG-2022, the patient was vaccinated with the second dose of haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 mL (route of administration was not provided) lot #U039951, expiration date: 22-JUN-2024, administered as prophylaxis which was accidentally diluted with 0.5 mL of normal saline (Incorrect dose administered) (Product preparation error). No additional adverse event (AE) information provided. This is one of several cases received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
NORMAL SALINE
Allergien
-
Vorherige Impfungen
-

VAERS 2412964

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
-
Beginn
25.07.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE.; PEDVAX HIB and ROTATEQ administred after temperature excursion.; This spontaneous report has been received from a nurse and refers to a patient of unknown gender and age.The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 25-JUL-2022, the patient was vaccinated with improperly storage dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (lot number: W004502, which was determined to be valid, with an expiration date on 10-OCT-2023), and Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) (lot number: U039951, which was determined to be valid, with an expiration date on 22-JUN-2024). Both were administered as prophylaxis (strengths, doses, routes of administration, and anatomical sites of injection were not reported). Administered doses were stored at a temperature of 23.8 degrees Celsius (C) during a time frame of 9 hours and 45 minutes (improper storage of product in use). There was no previous temperature excursion. No additional adverse events were reported in the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2412963

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; PEDVAX HIB and ROTATEQ administered after temperature excursion.; This spontaneous report has been received from a registered nurse concerning a unknown gender and age patient. No information regarding the patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided. On 25-JUL-2022, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot number U039951 had been verified to be a valid number; expiration date reported as 22-JUN-2023, and upon internal validation established as the same date, administered as prophylaxis ((strength, dose, units, vaccination scheme, frequency, route of administration and anatomical site of injection were not provided); and rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot number W004502 had been verified to be a valid number; expiration date reported as 09-OCT-2023, and upon internal validation established as the same date, administered as prophylaxis (strength, dose, units, vaccination scheme, frequency, route of administration and anatomical site of injection were not provided). Both vaccines were stored at a temperature of 23.8 degree Celsius (C) for the time frame of 9 hours and 45 minutes (product storage error). There was no previous temperature excursion and no additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2409330

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
12.08.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE/PQC reported.; PEDVAX HIB and ROTATQ administered after temperature excursion. Temperature 23.8C . Time frame 9 Hours 45 minutes.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not provided. On 25-JUL-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot number: W004502 has been verified to be a valid lot number with expiration date on 09-OCT-2023); and a dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot number U039951 has been verified to be a valid lot number with expiration date on 22-JUN-2024 (doses, strengths, routes of administration, anatomical injection sites and frequencies were not reported), both administered for prophylaxis. Both vaccines were stored at a temperature of 23.8 degree Celsius (C) for the time frame of 9 hours and 45 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2404236

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
08.08.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; PEDVAX HIB and ROTATQ administered after temperature excursion; This spontaneous report was received from a nurse referring to a patient of unspecified age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies was provided. On 25-JUL-2022, the patient was vaccinated with haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection (lot # U039951, expiration date: 22-JUN-2024, dose, strength, vaccination scheme frequency, and anatomical location were not reported) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid (lot # W004502), expiration date: 09-OCT-2023, dose, strength, and vaccination scheme frequency were not reported) for prophylaxis after a temperature excursion (temperature: 23.8 degree Celsius (C); time frame: 9 hours 45 minutes) (product storage error). It was reported there was no previous temperature excursion. No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2376713

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
OH
Alter
0,2
Geschlecht
F
Eingang
21.07.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Poor quality product administered

Symptomtext

Vaccine admin error non-viable vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
NKDA
Allergien
N/A
Vorherige Impfungen
-

VAERS 2371322

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U039951

gering
Staat
MD
Alter
1,0
Geschlecht
F
Eingang
16.07.2022
Impfdatum
20.06.2022
Beginn
30.06.2022
Tage bis Beginn
10,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose Incorrect route of product administration No adverse event Product preparation error

Symptomtext

The patient has had no side effects at this time.; PEDVAX HIB was accidently used as the diluent for MMR-II and VARIVAX instead of the Merck sterile diluent; Because of the PEDVAX HIB being used as the diluent for both MMR-II and VARIVAX, the patient received 1mL of PEDVAX HIB instead of the recommended dose of 0.5mL therefore receiving double the recommended dose of PEDVAX HIB.; Also, the PEDVAX HIB was given subcutaneously instead of intramuscularly since it was mixed as diluent with MMR-II and VARIVAX.; This spontaneous report was received from physician and refers to a 12-month-old female patient. The patient's concomitant therapy included pneumococcal vaccine conj 13v (crm197) (PREVENAR 13). The patient's concurrent conditions, medical history, allergies and drug reactions were not provided. On 30-JUN-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) , 0.5 ml, administered subcutaneously, lot #U011995, expiration date: 15-APR-2023 (strength and dose number was not provided), and varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 ml, administered subcutaneously, lot #U039726, expiration date: 15-DEC-2023 (strength and dose number were not provided) for prophylaxis. Haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot #U039951, expiration date: 22-JUN-2024 was accidentally used as the diluent for both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) instead of Merck sterile diluen (product preparation error). Because haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) being used as the diluent for both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX), the patient received 1 ml of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) instead of recommended dose of 0.5 ml, therefore receiving double the recommended dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (accidental overdose). Also, the haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) was given subcutaneously instead of intramuscularly since it was mixed as diluent with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) (incorrect route of product administration). The patient has had no side effects at this time (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-